This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
1647 , the Veterans Equal Access Act, which expands medical cannabis access to eligible military veterans. Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. Presently, V.A. At the time of introduction, Rep.
Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.
With the growing acceptance and legalization of cannabis, the pharmaceutical industry is taking serious hits, according to a 2022 novel study into the impact of cannabis legalization on pharmaceutical firms. What Is the Pharmaceutical Industry? pharmaceuticals). Still, most pharmaceuticals are heavily processed.
We will be exploring cannabis therapy for chronic conditions. There’s also neuropathic pain, which results from nerve damage, leading to conditions such as shingles or nerve compression. This is where exploring cannabis therapy for chronic conditions enters the picture as a promising alternative.
Fernando Fandio-Sende has had countless conversations with patients with autoimmune conditions. We’re aware that each person’s medical condition presents unique challenges with can be deeply personal. Dr. Sende offers Medical Marijuana recommendations for patients with one of Floridas qualifying conditions.
The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds.
There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. In Virginia, these families were simply asking to be able to possess the medicines they were able to access in other states. It removed qualifying conditions altogether. We need to do more.
In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. Cannabis is a really special case.
We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.
Epidiolex is the sole cannabis-derived pharmaceutical that has been approved by the FDA – although it is worth noting that the organization has also approved three synthetic cannabis-related products. Of course, it’s wonderful to see the FDA approve this substance to help those suffering from this rare condition.
Pharmaceutical grade cannabis is relatively new in parts of the world. The availability of medications for patients varies from country to condition. These estimates vary drastically source to source, which reflects what conditions make a patient eligible for a cannabis-based medicine.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because cannabis is still a schedule 1 drug in the U.S.,
On July 1, the process of procuring pharmaceutical-approved cannabis was simplified for individuals residing across the state, where the first licensed medical marijuana dispensary opened its doors in August 2020. The latest changes to Virginia’s medical cannabis law adds to a growing list of amendments aimed at improving patient access.
It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients.
Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.
Access Control. Since the ERP is equipped with all of the company’s information, the access to data is controlled. and each user can only access part of the information. The QA department usually defines the user access to be controlled and each user will have his. Some users can have unique privileges to.
Legislation is pending, House Bill 1272, to expand access to medical cannabis in North Dakota. Legislation is pending, House Bill 350, to expand medical cannabis access. Legislation is pending, House Bill 335, to expand access to medical cannabis in New Hampshire. Click here to email your lawmakers in support of medical access.
of respondents who received Medical Cannabis treatment reported improvement in their condition and significant reductions to pain levels. An increasing number of older people are seeking the treatment for conditions such as inflammatory arthritis, autoimmune disease and chronic pain. namely Australia’s aging population.
Legislation has been reintroduced from last year, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Click here to email your lawmakers in support of banking access.
Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).
Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .
Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients were granted access to low-THC marijuana oil. Andrew Turnage, the executive director of the Georgia Access to Medical Cannabis Commission, spoke on this fact.
–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. The live webcast can be accessed here and on the investor page of Marinus’ website. The condition is caused by inherited mutations in either the TSC1 gene or the TSC2 gene. About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc.
At the state level this week, activists gathered in Denver in conjunction with Colorado and Denver NORML chapters to lobby their state lawmakers in favor of workplace drug testing reforms, social consumption, parental protections and expanding access to the state’s medical cannabis program. HI resident? IA resident? MO resident?
A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.
The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. By expanding access and, thus use, legalization could permit cannabis to compete with conventional pharmaceuticals.
Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. Click here to email your lawmakers in support of medical cannabis access in school. Legislation is pending, House Bill 673 / Senate Bill 1430, to expand medical cannabis access.
The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”
By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.
Can businesses cultivate cannabis for pharmaceutical research? The conditions of the relevant licenses and permits. Several proposals aim to: Expand medicinal cannabis access. Pharmacies must: Be registered in Australia. Obtain TGA and state regulatory approvals. Follow strict patient verification and dispensing rules.
5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.
Legislation is pending, House Bill 268 and House Bill 528, to allow those convicted of simple marijuana possession to petition the court to restrict access to their records. Send a message to your lawmakers in support of access to edibles. Send a message to your lawmakers in opposition to arbitrary THC limits. GA resident? HI resident?
Why does Argentina have the conditions to be an important producer in the cannabis and hemp industry? According to Kulfas, the benefits will include: Health rights: supply of medical cannabis to ensure better access to health. ley cáñamo argentina. Employment: Generation of quality jobs. Exports: Potential foreign exchange generation.
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.
Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products. Poland and cannabis. Can you grow your own weed?
It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use. CBD for Anxiety.
Patients dealing with chronic pain from numerous conditions are finding relief in cannabis. Healthcare, tennis player and injured black man or athlete with muscle pain or inflammation after exercise or workout Chronic Pain and Challenges Chronic pain is a long-lasting condition that persists for more than 3-6 months, sometimes lasting years.
To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. This can be as simple as taking a picture of a prescription bottle you have been given to treat your condition. What Conditions Qualify for Medical Marijuana Cards in Virginia?
Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. Under the terms of the agreement OCT will use reasonable efforts to develop and commercialise: (i) at least one CBD derivative; (ii) at least one CBG derivative; and (iii) at least one THC derivative, as pharmaceutical drug products.
AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Unfortunately, this number is expected to increase rapidly with legalized marijuana and access to substances that have five times the THC concentration of regular marijuana,” said Mr. Allen. “We About Anebulo Pharmaceuticals, Inc. and Australia.
This acquisition will accelerate Khiron’s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies. Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients.
The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. Even though the use of CBD for medicine has the support of the FDA, the methods of extracting CBD and the marketing of CBD products will likely become the subjects of high scrutiny.
Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. The Therapeutic Goods Administration (TGA) issued 73 infringement notices totalling $972,360 between the medicinal cannabis companies MGC Pharmaceuticals Ltd, Cannatrek Ltd and Little Green Pharma Ltd.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content